{
  "id": "ms-chronic-management",
  "title": "Multiple Sclerosis - Chronic Management",
  "version": "1.0",
  "icd10": [
    "** G35 (Multiple sclerosis)"
  ],
  "scope": "** Long-term management of multiple sclerosis in adults including disease-modifying therapy (DMT) selection and monitoring, relapse management, symptom management, and pregnancy considerations. Excludes initial diagnosis workup (see MS New Diagnosis template) and acute relapse management as primary focus.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Baseline Labs (Before Starting DMT)": [
        {
          "item": "CBC with differential (CPT 85025)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Baseline; many DMTs affect counts",
          "target": "Normal"
        },
        {
          "item": "CMP (CPT 80053)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hepatic/renal function",
          "target": "Normal"
        },
        {
          "item": "LFTs (AST, ALT, bilirubin) (CPT 80076)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Baseline for hepatotoxic DMTs",
          "target": "Normal"
        },
        {
          "item": "TSH (CPT 84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Alemtuzumab causes thyroid disease",
          "target": "Normal"
        },
        {
          "item": "Urinalysis (CPT 81003)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "UTI causes pseudorelapse",
          "target": "Negative"
        },
        {
          "item": "Vitamin D (25-OH) (CPT 82306)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Deficiency common; may affect MS",
          "target": ">30 ng/mL (target 40-60)"
        },
        {
          "item": "Hepatitis B/C serology (CPT 80074)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Reactivation risk with some DMTs",
          "target": "Document status"
        },
        {
          "item": "HIV (CPT 87389)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Before immunosuppressive therapy",
          "target": "Negative"
        },
        {
          "item": "VZV IgG",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Vaccinate if seronegative before DMTs",
          "target": "Document; vaccinate if negative"
        },
        {
          "item": "JC virus antibody (anti-JCV) (CPT 87798)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "PML risk stratification for natalizumab",
          "target": "Document index"
        },
        {
          "item": "Pregnancy test (CPT 84703)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Most DMTs contraindicated in pregnancy",
          "target": "Negative before starting DMT"
        }
      ],
      "Monitoring Labs (On DMT)": [
        {
          "item": "CBC (CPT 85025)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Lymphopenia (many DMTs), cytopenias",
          "target": "Per DMT thresholds"
        },
        {
          "item": "LFTs (CPT 80076)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Hepatotoxicity monitoring",
          "target": "Normal"
        },
        {
          "item": "Lymphocyte count",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Critical for many DMTs",
          "target": "Per DMT; usually >200-500"
        },
        {
          "item": "JCV antibody (if on natalizumab) (CPT 87798)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "PML risk; repeat q6 months",
          "target": "Monitor index"
        },
        {
          "item": "TSH (if on alemtuzumab) (CPT 84443)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Autoimmune thyroid disease",
          "target": "Normal; monthly × 48 months"
        },
        {
          "item": "Creatinine, urinalysis (alemtuzumab) (CPT 81003)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "Autoimmune nephropathy",
          "target": "Normal; monthly × 48 months"
        },
        {
          "item": "Platelet count (alemtuzumab)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "rationale": "ITP risk",
          "target": "Normal; monthly × 48 months"
        }
      ]
    },
    "Imaging & Studies": {
      "Monitoring MRI": [
        {
          "item": "MRI brain with and without contrast (CPT 70553)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Baseline, 6 months, then annually",
          "target": "No new/enlarging lesions",
          "contraindications": "Pacemaker, metal; gadolinium in renal disease"
        },
        {
          "item": "MRI cervical spine with and without contrast (CPT 72156)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Baseline, then PRN or q2-3 years",
          "target": "No new lesions",
          "contraindications": "Same"
        },
        {
          "item": "MRI thoracic spine (if indicated) (CPT 72157)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "If thoracic symptoms",
          "target": "No new lesions",
          "contraindications": "Same"
        }
      ],
      "Additional Studies": [
        {
          "item": "OCT (optical coherence tomography) (CPT 92134)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "Baseline, annually",
          "target": "Stable RNFL thickness",
          "contraindications": "None"
        },
        {
          "item": "Evoked potentials (VEP, SSEP) (CPT 95930)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "EXT",
          "ICU": "-",
          "timing": "If clinical uncertainty",
          "target": "Baseline; monitor progression",
          "contraindications": "None"
        },
        {
          "item": "Urodynamic studies",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "timing": "If bladder symptoms",
          "target": "Characterize dysfunction",
          "contraindications": "None"
        }
      ]
    },
    "Treatment": {
      "Disease-Modifying Therapies - Platform/Injectable (Moderate Efficacy)": [
        {
          "item": "Glatiramer acetate (Copaxone)",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg",
                "orderSentence": "Glatiramer acetate (Copaxone) 20 mg SC"
              }
            ],
            "route": "SC",
            "instructions": "20 mg SC daily or 40 mg SC 3×/week",
            "orderSentence": "Glatiramer acetate (Copaxone) 20 mg SC"
          },
          "pretreatment": "-",
          "contraindications": "Hypersensitivity",
          "monitoring": "Injection site reactions; lipoatrophy",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Interferon beta-1a (Avonex)",
          "route": "IM",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 mcg",
                "orderSentence": "Interferon beta-1a (Avonex) 30 mcg IM"
              }
            ],
            "route": "IM",
            "instructions": "30 mcg IM weekly",
            "orderSentence": "Interferon beta-1a (Avonex) 30 mcg IM"
          },
          "pretreatment": "-",
          "contraindications": "Depression, hepatic disease",
          "monitoring": "CBC, LFTs q6 months; flu-like symptoms",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Interferon beta-1a (Rebif)",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "44 mcg",
                "orderSentence": "Interferon beta-1a (Rebif) 44 mcg SC"
              }
            ],
            "route": "SC",
            "instructions": "22 or 44 mcg SC 3×/week (titrate)",
            "orderSentence": "Interferon beta-1a (Rebif) 44 mcg SC"
          },
          "pretreatment": "-",
          "contraindications": "Same",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Interferon beta-1b (Betaseron, Extavia)",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mcg",
                "orderSentence": "Interferon beta-1b (Betaseron, Extavia) 250 mcg SC"
              }
            ],
            "route": "SC",
            "instructions": "250 mcg SC every other day",
            "orderSentence": "Interferon beta-1b (Betaseron, Extavia) 250 mcg SC"
          },
          "pretreatment": "-",
          "contraindications": "Same",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Peginterferon beta-1a (Plegridy)",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "125 mcg",
                "orderSentence": "Peginterferon beta-1a (Plegridy) 125 mcg SC"
              }
            ],
            "route": "SC",
            "instructions": "125 mcg SC q2 weeks",
            "orderSentence": "Peginterferon beta-1a (Plegridy) 125 mcg SC"
          },
          "pretreatment": "-",
          "contraindications": "Same",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Disease-Modifying Therapies - Oral (Moderate-High Efficacy)": [
        {
          "item": "Dimethyl fumarate (Tecfidera)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "120 mg",
                "orderSentence": "Dimethyl fumarate (Tecfidera) 120 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "120 mg BID × 7 days, then 240 mg BID",
            "orderSentence": "Dimethyl fumarate (Tecfidera) 120 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Lymphopenia (<500), PML risk",
          "monitoring": "CBC q6 months; LFTs; GI symptoms, flushing",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Diroximel fumarate (Vumerity)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "231 mg",
                "orderSentence": "Diroximel fumarate (Vumerity) 231 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "231 mg BID × 7 days, then 462 mg BID",
            "orderSentence": "Diroximel fumarate (Vumerity) 231 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Same",
          "monitoring": "Same; less GI effects",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Monomethyl fumarate (Bafiertam)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "95 mg",
                "orderSentence": "Monomethyl fumarate (Bafiertam) 95 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "95 mg BID × 7 days, then 190 mg BID",
            "orderSentence": "Monomethyl fumarate (Bafiertam) 95 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Same",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Teriflunomide (Aubagio)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "14 mg",
                "orderSentence": "Teriflunomide (Aubagio) 14 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "14 mg daily",
            "orderSentence": "Teriflunomide (Aubagio) 14 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Pregnancy (teratogenic), hepatic disease",
          "monitoring": "LFTs monthly × 6mo; CBC; BP; pregnancy test; accelerated elimination available",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Fingolimod (Gilenya)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg",
                "orderSentence": "Fingolimod (Gilenya) 0.5 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "0.5 mg daily; first dose observation 6h",
            "orderSentence": "Fingolimod (Gilenya) 0.5 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Recent MI, unstable angina, heart block, bradycardia",
          "monitoring": "First-dose cardiac monitoring (6h); ophtho exam (macular edema); LFTs; varicella status; lymphocyte count",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Siponimod (Mayzent)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg",
                "orderSentence": "Siponimod (Mayzent) 2 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Titration pack, then 2 mg daily (1 mg if CYP2C9 *2/*3); approved for active SPMS",
            "orderSentence": "Siponimod (Mayzent) 2 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Same as fingolimod; CYP2C9 testing required",
          "monitoring": "Same as fingolimod; CYP2C9 genotype",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ozanimod (Zeposia)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.23 mg",
                "orderSentence": "Ozanimod (Zeposia) 0.23 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Titration: 0.23 mg × 4d, 0.46 mg × 3d, then 0.92 mg daily",
            "orderSentence": "Ozanimod (Zeposia) 0.23 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Same as fingolimod",
          "monitoring": "Same; less first-dose effect",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ponesimod (Ponvory)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg",
                "orderSentence": "Ponesimod (Ponvory) 20 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "Titration over 14 days to 20 mg daily",
            "orderSentence": "Ponesimod (Ponvory) 20 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Same as fingolimod",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Cladribine (Mavenclad)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "3.5 mg/kg",
                "orderSentence": "Cladribine (Mavenclad) 3.5 mg/kg -"
              }
            ],
            "route": "-",
            "instructions": "3.5 mg/kg total over 2 years (Year 1: 1.75 mg/kg in 2 cycles; Year 2: same); highly active RRMS",
            "orderSentence": "Cladribine (Mavenclad) 3.5 mg/kg -"
          },
          "pretreatment": "-",
          "contraindications": "Pregnancy, HIV, active infection, malignancy",
          "monitoring": "CBC q2 months Year 1, then q6 months; lymphocyte >500-800 to start",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Disease-Modifying Therapies - Infusion (High Efficacy)": [
        {
          "item": "Natalizumab (Tysabri)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg",
                "orderSentence": "Natalizumab (Tysabri) 300 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "300 mg IV q4 weeks",
            "orderSentence": "Natalizumab (Tysabri) 300 mg IV"
          },
          "pretreatment": "-",
          "contraindications": "PML risk (JCV+, prior immunosuppression, duration >2y)",
          "monitoring": "JCV antibody q6 months; MRI q6-12 months; infusion reactions",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ocrelizumab (Ocrevus)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg",
                "orderSentence": "Ocrelizumab (Ocrevus) 300 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "300 mg IV × 2 doses (2 weeks apart), then 600 mg IV q6 months",
            "orderSentence": "Ocrelizumab (Ocrevus) 300 mg IV"
          },
          "pretreatment": "-",
          "contraindications": "Active Hep B, active infection",
          "monitoring": "Pre-infusion CBC, LFTs; HBV screening; infection monitoring; malignancy screening",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ofatumumab (Kesimpta)",
          "route": "SC",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg",
                "orderSentence": "Ofatumumab (Kesimpta) 20 mg SC"
              }
            ],
            "route": "SC",
            "instructions": "20 mg SC weeks 0, 1, 2, then 20 mg SC monthly",
            "orderSentence": "Ofatumumab (Kesimpta) 20 mg SC"
          },
          "pretreatment": "-",
          "contraindications": "Same as ocrelizumab",
          "monitoring": "Same; self-administered SC",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Ublituximab (Briumvi)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "150 mg",
                "orderSentence": "Ublituximab (Briumvi) 150 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "150 mg IV day 1, 450 mg IV day 15, then 450 mg IV q6 months",
            "orderSentence": "Ublituximab (Briumvi) 150 mg IV"
          },
          "pretreatment": "-",
          "contraindications": "Same as ocrelizumab",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Alemtuzumab (Lemtrada)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "12 mg",
                "orderSentence": "Alemtuzumab (Lemtrada) 12 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "Year 1: 12 mg IV daily × 5 days; Year 2: 12 mg IV daily × 3 days; highly active MS, REMS",
            "orderSentence": "Alemtuzumab (Lemtrada) 12 mg IV"
          },
          "pretreatment": "-",
          "contraindications": "Active infection, HIV, immunocompromised",
          "monitoring": "CBC, LFTs, creatinine, urinalysis, TSH monthly × 48 months after last dose; REMS program",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Treatment for Progressive MS": [
        {
          "item": "Ocrelizumab (PPMS)",
          "route": "PO",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg",
                "orderSentence": "Ocrelizumab (PPMS) 300 mg PO"
              }
            ],
            "route": "PO",
            "instructions": "300 mg × 2, then 600 mg q6 months",
            "orderSentence": "Ocrelizumab (PPMS) 300 mg PO"
          },
          "pretreatment": "-",
          "contraindications": "Per above",
          "monitoring": "Per above; only approved for PPMS",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Siponimod (active SPMS)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Siponimod (active SPMS) N/A -"
              }
            ],
            "route": "-",
            "instructions": "Per above",
            "orderSentence": "Siponimod (active SPMS) N/A -"
          },
          "pretreatment": "-",
          "contraindications": "Per above",
          "monitoring": "Per above",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Acute Relapse Treatment": [
        {
          "item": "Methylprednisolone IV (CPT 96365)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1000 mg",
                "orderSentence": "Methylprednisolone IV (CPT 96365) 1000 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "1000 mg IV daily × 3-5 days",
            "orderSentence": "Methylprednisolone IV (CPT 96365) 1000 mg IV"
          },
          "contraindications": "Active infection (relative), uncontrolled DM",
          "monitoring": "Glucose, BP, sleep, psychiatric",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Prednisone oral (alternative)",
          "route": "IV",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "1250 mg",
                "orderSentence": "Prednisone oral (alternative) 1250 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "1250 mg PO daily × 3-5 days (bioequivalent to IV)",
            "orderSentence": "Prednisone oral (alternative) 1250 mg IV"
          },
          "contraindications": "Same",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-"
        },
        {
          "item": "Plasma exchange (PLEX) (CPT 36514)",
          "route": "-",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Plasma exchange (PLEX) (CPT 36514) N/A -"
              }
            ],
            "route": "-",
            "instructions": "5-7 exchanges over 2 weeks; severe relapse not responding to steroids",
            "orderSentence": "Plasma exchange (PLEX) (CPT 36514) N/A -"
          },
          "contraindications": "Hemodynamic instability",
          "monitoring": "Electrolytes, coagulation",
          "ED": "-",
          "HOSP": "STAT",
          "OPD": "-",
          "ICU": "-"
        },
        {
          "item": "ACTH gel (Acthar)",
          "route": "IM",
          "indication": "-",
          "dosing": {
            "doseOptions": [
              {
                "text": "80-120 units",
                "orderSentence": "ACTH gel (Acthar) 80-120 units IM"
              }
            ],
            "route": "IM",
            "instructions": "80-120 units IM daily × 2-3 weeks; alternative to steroids",
            "orderSentence": "ACTH gel (Acthar) 80-120 units IM"
          },
          "contraindications": "Same as steroids",
          "monitoring": "Same",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-"
        }
      ],
      "Symptom Management": [
        {
          "item": "Amantadine",
          "dosing": {
            "doseOptions": [
              {
                "text": "100 mg",
                "orderSentence": "Amantadine 100 mg -"
              }
            ],
            "route": "-",
            "instructions": "100 mg BID",
            "orderSentence": "Amantadine 100 mg -"
          },
          "monitoring": "Livedo reticularis"
        },
        {
          "item": "Baclofen",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Baclofen 5 mg -"
              }
            ],
            "route": "-",
            "instructions": "5 mg TID, titrate to 20 mg TID",
            "orderSentence": "Baclofen 5 mg -"
          },
          "monitoring": "Sedation, weakness"
        },
        {
          "item": "Dalfampridine (Ampyra)",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg",
                "orderSentence": "Dalfampridine (Ampyra) 10 mg -"
              }
            ],
            "route": "-",
            "instructions": "10 mg BID",
            "orderSentence": "Dalfampridine (Ampyra) 10 mg -"
          },
          "monitoring": "Seizures (discontinue if occurs)"
        },
        {
          "item": "Oxybutynin",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 mg",
                "orderSentence": "Oxybutynin 5 mg -"
              }
            ],
            "route": "-",
            "instructions": "5 mg BID-TID",
            "orderSentence": "Oxybutynin 5 mg -"
          },
          "monitoring": "Dry mouth, cognitive effects"
        },
        {
          "item": "Clean intermittent cath",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Clean intermittent cath N/A -"
              }
            ],
            "route": "-",
            "instructions": "Schedule-based",
            "orderSentence": "Clean intermittent cath N/A -"
          },
          "monitoring": "UTI prevention"
        },
        {
          "item": "Gabapentin",
          "dosing": {
            "doseOptions": [
              {
                "text": "300-1200 mg",
                "orderSentence": "Gabapentin 300-1200 mg -"
              }
            ],
            "route": "-",
            "instructions": "300-1200 mg TID",
            "orderSentence": "Gabapentin 300-1200 mg -"
          },
          "monitoring": "Sedation"
        },
        {
          "item": "SSRIs (sertraline, escitalopram)",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "SSRIs (sertraline, escitalopram) N/A -"
              }
            ],
            "route": "-",
            "instructions": "Standard dosing",
            "orderSentence": "SSRIs (sertraline, escitalopram) N/A -"
          },
          "monitoring": "Per SSRI"
        },
        {
          "item": "Cognitive rehabilitation",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Cognitive rehabilitation N/A -"
              }
            ],
            "route": "-",
            "instructions": "PT/OT/neuropsych referral",
            "orderSentence": "Cognitive rehabilitation N/A -"
          },
          "monitoring": "Progress"
        },
        {
          "item": "Propranolol",
          "dosing": {
            "doseOptions": [
              {
                "text": "40-160 mg/day",
                "orderSentence": "Propranolol 40-160 mg/day -"
              }
            ],
            "route": "-",
            "instructions": "40-160 mg/day",
            "orderSentence": "Propranolol 40-160 mg/day -"
          },
          "monitoring": "HR, BP"
        },
        {
          "item": "Sildenafil (male)",
          "dosing": {
            "doseOptions": [
              {
                "text": "25-100 mg",
                "orderSentence": "Sildenafil (male) 25-100 mg -"
              }
            ],
            "route": "-",
            "instructions": "25-100 mg PRN",
            "orderSentence": "Sildenafil (male) 25-100 mg -"
          },
          "monitoring": "BP with nitrates"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "MS specialist/Neurologist",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "All patients; DMT selection and monitoring"
        },
        {
          "item": "Neuro-ophthalmology",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Optic neuritis, visual symptoms"
        },
        {
          "item": "Physical therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Gait, balance, strengthening, spasticity"
        },
        {
          "item": "Occupational therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "ADLs, fatigue management, adaptive equipment"
        },
        {
          "item": "Speech therapy",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Dysphagia, dysarthria, cognitive-communication"
        },
        {
          "item": "Neuropsychology",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Cognitive assessment, rehabilitation"
        },
        {
          "item": "Urology",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Bladder management, urodynamics"
        },
        {
          "item": "Psychiatry",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Depression, anxiety, pseudobulbar affect"
        },
        {
          "item": "Maternal-fetal medicine",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Pregnancy planning, high-risk pregnancy"
        },
        {
          "item": "Social work",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "-",
          "indication": "Disability services, resources"
        }
      ],
      "Patient/Family Instructions": [
        {
          "item": "MS is a chronic condition requiring lifelong management",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Take DMT as prescribed; do not stop without consulting neurologist",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report new symptoms promptly (may be relapse)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid overheating (Uhthoff phenomenon); swimming and cooling vests help",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Vaccination: Get flu and COVID vaccines; avoid live vaccines on most DMTs",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Infections can trigger pseudorelapses; treat promptly",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Pregnancy planning: Many DMTs contraindicated; discuss before conception",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "National MS Society (nationalmssociety.org) for resources",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Regular exercise (aerobic + strength) improves fatigue, mood, function",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Maintain vitamin D levels (40-60 ng/mL); supplement if low",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "No smoking (worsens progression)",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Healthy diet (Mediterranean-style)",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "Adequate sleep",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Stress management",
          "ED": "-",
          "HOSP": "-",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid excessive heat exposure",
          "ED": "-",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Neuromyelitis optica spectrum disorder",
      "features": "AQP4-IgG+, longitudinally extensive myelitis, bilateral optic neuritis",
      "tests": "AQP4-IgG, MOG-IgG; MRI pattern"
    },
    {
      "diagnosis": "MOG antibody disease",
      "features": "MOG-IgG+, optic neuritis, myelitis, ADEM-like",
      "tests": "MOG-IgG"
    },
    {
      "diagnosis": "CNS vasculitis",
      "features": "Progressive, multifocal; systemic symptoms",
      "tests": "Angiography, biopsy"
    },
    {
      "diagnosis": "Neurosarcoidosis",
      "features": "Leptomeningeal enhancement, systemic sarcoid",
      "tests": "ACE level, chest imaging, biopsy"
    },
    {
      "diagnosis": "Lyme disease",
      "features": "Endemic area, systemic symptoms",
      "tests": "Lyme serology"
    },
    {
      "diagnosis": "B12 deficiency myelopathy",
      "features": "Subacute combined degeneration, macrocytic anemia",
      "tests": "B12 level, MMA"
    },
    {
      "diagnosis": "Migraine with MRI lesions",
      "features": "Headache predominant; non-specific white matter lesions",
      "tests": "Clinical; lesion pattern different"
    }
  ],
  "evidence": [
    {
      "recommendation": "High-efficacy DMTs reduce relapses/progression",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple RCTs"
    },
    {
      "recommendation": "Ocrelizumab effective for PPMS",
      "evidenceLevel": "Class I, Level A",
      "source": "[ORATORIO trial](https://pubmed.ncbi.nlm.nih.gov/28002688/)"
    },
    {
      "recommendation": "Early high-efficacy treatment improves long-term outcomes",
      "evidenceLevel": "Class II, Level B",
      "source": "Observational data"
    },
    {
      "recommendation": "IV steroids for acute relapse",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple RCTs"
    },
    {
      "recommendation": "Vitamin D supplementation may reduce relapse",
      "evidenceLevel": "Class II, Level B",
      "source": "Observational data; RCTs ongoing"
    },
    {
      "recommendation": "Exercise improves fatigue and quality of life",
      "evidenceLevel": "Class I, Level A",
      "source": "Multiple RCTs"
    },
    {
      "recommendation": "Natalizumab PML risk stratification",
      "evidenceLevel": "Class I",
      "source": "JCV antibody testing; risk algorithms"
    },
    {
      "recommendation": "Siponimod for active SPMS",
      "evidenceLevel": "Class I, Level A",
      "source": "[EXPAND trial](https://pubmed.ncbi.nlm.nih.gov/29576505/)"
    }
  ],
  "monitoring": [
    {
      "item": "EDSS score",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "q6-12 months",
      "action": "Assess treatment efficacy"
    },
    {
      "item": "MRI brain",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Baseline, 6mo, then annually",
      "action": "Treatment escalation"
    },
    {
      "item": "Relapse count",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Ongoing",
      "action": "Treatment escalation"
    },
    {
      "item": "CBC (most DMTs)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "q3-6 months",
      "action": "Hold DMT if low"
    },
    {
      "item": "LFTs (hepatotoxic DMTs)",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "q3-6 months",
      "action": "Hold DMT if elevated"
    },
    {
      "item": "JCV antibody (natalizumab)",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "q6 months",
      "action": "Switch if high-risk"
    },
    {
      "item": "Vitamin D",
      "ED": "-",
      "HOSP": "-",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "Annually",
      "action": "Supplement"
    },
    {
      "item": "Urinalysis",
      "ED": "-",
      "HOSP": "ROUTINE",
      "OPD": "ROUTINE",
      "ICU": "-",
      "frequency": "If relapse suspected",
      "action": "Treat UTI"
    }
  ],
  "disposition": [
    {
      "disposition": "Outpatient management",
      "criteria": "Stable MS, on appropriate DMT, routine monitoring"
    },
    {
      "disposition": "Admit to hospital",
      "criteria": "Acute relapse requiring IV steroids, severe relapse, functional decline"
    },
    {
      "disposition": "MS specialist follow-up",
      "criteria": "q3-6 months while adjusting DMT; q6-12 months once stable"
    },
    {
      "disposition": "Urgent follow-up",
      "criteria": "New relapse, DMT side effects, significant progression"
    }
  ]
}